It has been demonstrated that autophagy-related 5 (ATG5) and Parkin increase in the cerebrospinal fluid and serum of MS patients, highlighting these autophagy/mitophagy elements as molecular markers of the disease’s active phase [86, 87]. This evidence concerns the gene ATG5 and myeloid sarcoma.